Hua Medicine (Shanghai) Ltd.
HUMDF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $217,432 | $153,229 | $102,663 | $6,279 |
| % Growth | 41.9% | 49.3% | 1,535% | – |
| Cost of Goods Sold | $99,613 | $76,267 | $54,901 | $12,952 |
| Gross Profit | $117,819 | $76,962 | $47,762 | -$6,673 |
| % Margin | 54.2% | 50.2% | 46.5% | -106.3% |
| R&D Expenses | $65,821 | $95,316 | $119,776 | $100,539 |
| G&A Expenses | $53,120 | $55,656 | $61,099 | $70,131 |
| SG&A Expenses | $117,275 | $147,720 | $122,217 | $96,965 |
| Sales & Mktg Exp. | $64,155 | $92,064 | $61,118 | $26,834 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $183,096 | $243,036 | $241,993 | $197,504 |
| Operating Income | -$65,277 | -$166,074 | -$194,231 | -$204,177 |
| % Margin | -30% | -108.4% | -189.2% | -3,251.7% |
| Other Income/Exp. Net | $1,249,223 | $58,171 | $51,990 | $83,039 |
| Pre-Tax Income | $1,183,946 | -$107,903 | -$142,241 | -$121,138 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $1,183,946 | -$107,903 | -$142,241 | -$121,138 |
| % Margin | 544.5% | -70.4% | -138.6% | -1,929.3% |
| EPS | 1.2 | -0.11 | -0.145 | -0.124 |
| % Growth | 1,192.9% | 24.3% | -17.3% | – |
| EPS Diluted | 1.2 | -0.11 | -0.145 | -0.124 |
| Weighted Avg Shares Out | 994,913 | 982,151 | 980,648 | 980,113 |
| Weighted Avg Shares Out Dil | 992,183 | 982,137 | 980,647 | 980,108 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3,371 | $3,263 | $0 | $4,190 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $7,272 | $6,788 | $7,532 | $7,935 |
| EBITDA | -$58,005 | -$159,286 | -$186,699 | -$196,242 |
| % Margin | -26.7% | -104% | -181.9% | -3,125.4% |